Literature DB >> 8786798

Age-related changes in hippocampal drug facilitation of memory processing in SAMP8 mice.

J F Flood1, F J Harris, J E Morley.   

Abstract

SAMP8/TaJf(P8) mouse strain has an inherited age-related impairment of learning and memory, while age-matched subjects of the closely related SAMR1/TaJf(R1) show no impairment. After training on footshock avoidance, P8 and R1 received a drug injection into the hippocampus. Retention was tested 1 week later. The results indicate that bicuculline (GABA antagonist), SKF38393 (DA agonist), and ST587 (NE agonist) facilitated retention with little change in the dose-response curves for P8 mice 4, 8, and 12 months of age. L-glutamate, acting at the NMDA receptor, showed a modest decline in ability to improve retention with increasing age. Arecoline, a muscarinic agonist, had the strongest trend for an age-related decline in potency. The same drug treatments yielded dose-dependent facilitation of retention but no age-related changes in R1 mice. Reduced cholinergic activity in the hippocampus may be, in part, responsible for age-related decline in memory retention in P8 mice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8786798     DOI: 10.1016/0197-4580(95)02007-1

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  7 in total

1.  Nitric oxide activity and isoenzyme expression in the senescence-accelerated mouse p8 model of Alzheimer's disease: effects of anti-amyloid antibody and antisense treatments.

Authors:  Abbas K Ali; William A Banks; Vijaya B Kumar; Gul N Shah; Jessica L Lynch; Susan A Farr; Melissa A Fleegal-DeMotta; John E Morley
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-06-16       Impact factor: 6.053

2.  Highly water pressurized brown rice improves cognitive dysfunction in senescence-accelerated mouse prone 8 and reduces amyloid beta in the brain.

Authors:  Michiaki Okuda; Yuki Fujita; Takuya Katsube; Hiromasa Tabata; Katsumi Yoshino; Michio Hashimoto; Hachiro Sugimoto
Journal:  BMC Complement Altern Med       Date:  2018-03-27       Impact factor: 3.659

3.  The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.

Authors:  Henrik H Hansen; Katrine Fabricius; Pernille Barkholt; Michael L Niehoff; John E Morley; Jacob Jelsing; Charles Pyke; Lotte Bjerre Knudsen; Susan A Farr; Niels Vrang
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

4.  LW-AFC Effects on N-glycan Profile in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.

Authors:  Jianhui Wang; Xiaorui Cheng; Ju Zeng; Jiangbei Yuan; Zhongfu Wang; Wenxia Zhou; Yongxiang Zhang
Journal:  Aging Dis       Date:  2017-02-01       Impact factor: 6.745

5.  The Chinese herbal formula Fuzheng Quxie Decoction attenuates cognitive impairment and protects cerebrovascular function in SAMP8 mice.

Authors:  Feixue Wang; Jianchao Feng; Yang Yang; Jiangang Liu; Meixia Liu; Zhiyong Wang; Hui Pei; Yun Wei; Hao Li
Journal:  Neuropsychiatr Dis Treat       Date:  2018-11-09       Impact factor: 2.570

Review 6.  Alzheimer's Disease and Hippocampal Adult Neurogenesis; Exploring Shared Mechanisms.

Authors:  Carolyn Hollands; Nancy Bartolotti; Orly Lazarov
Journal:  Front Neurosci       Date:  2016-05-03       Impact factor: 4.677

7.  Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.

Authors:  Henrik H Hansen; Katrine Fabricius; Pernille Barkholt; Pernille Kongsbak-Wismann; Chantal Schlumberger; Jacob Jelsing; Dick Terwel; Annelies Termont; Charles Pyke; Lotte Bjerre Knudsen; Niels Vrang
Journal:  PLoS One       Date:  2016-07-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.